Sanofi Discontinues C. Difficile Tx Development
Monthly Prescribing Reference
Sanofi has decided to discontinue the clinical development of its proposed Clostridium difficile vaccine after an interim analysis concluded that the probability of the Phase 3 study meeting its primary objective was low. The interim analysis was conducted by the Independent Data Monitoring Committee ...
Sanofi Discontinues C. Difficile Reference Sanofi d
-
- Administrator
- Posts: 12688
- Joined: Sat Aug 06, 2005 8:00 pm
-
- Long Time Contributor
- Posts: 3035
- Joined: Thu Sep 18, 2014 12:01 pm
Re: Sanofi Discontinues C. Difficile Reference Sanofi d
NOT good news........
-
- Administrator
- Posts: 12688
- Joined: Sat Aug 06, 2005 8:00 pm
Re: Sanofi Discontinues C. Difficile Reference Sanofi d
Agree. Disappointung.
Who is online
Users browsing this forum: No registered users and 5 guests